OEC works with Medtronic

Article

C-arm manufacturer OEC Medical of Salt Lake City has announced that it will equip Medtronic AneuRx's domestic and international clinical investigator sites with its OEC Series 9600 vascular mobile imaging systems. The clinical sites are investigating the

C-arm manufacturer OEC Medical of Salt Lake City has announced that it will equip Medtronic AneuRx's domestic and international clinical investigator sites with its OEC Series 9600 vascular mobile imaging systems. The clinical sites are investigating the AneuRx stent graft for the endovascular repair of abdominal aortic aneurysms (AAA).

OEC's Series 9600 will guide and position catheters and other devices relative to the procedure via digital fluoroscopy, and then will confirm procedural results prior to leaving the operating room with an immediate postprocedural subtraction angiogram, according to the companies.

The AneuRx stent graft, which allows physicians to treat AAA by deploying a stent graft through a catheter placed in the femoral artery, is being evaluated at clinical centers in the U.S. under an investigational device exemption from the Food and Drug Administration, according to the companies. The stent graft has received European approval and is in the early phase of European market introduction. Medtronic AneuRx is a Cupertino, CA-based subsidiary of Medtronic.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.